Literature DB >> 12383233

In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord.

David J Martens1, Raewyn M Seaberg, Derek van der Kooy.   

Abstract

Stem cells isolated from the fourth ventricle and spinal cord form neurospheres in vitro in response to basic fibroblast growth factor (FGF2)+heparin (H) or epidermal growth factor (EGF)+FGF2 together. To determine whether these growth factor conditions are sufficient to induce stem cells within the fourth ventricle and spinal cord to proliferate and expand their progeny in vivo, we infused EGF and FGF2, alone or together, with or without H, into the fourth ventricle for 6 days via osmotic minipumps. Animals were injected with bromodeoxyuridine (BrdU) on days 4, 5 and 6 of infusion in order to label cells proliferating in response to the growth factors. Infusions of EGF+FGF2+H into the fourth ventricle resulted in the largest proliferative effect, a 10.8-fold increase in the number of BrdU+ cells around the fourth ventricle, and a 33.5-fold increase in the number of BrdU+ cells around the central canal of the spinal cord, as compared to vehicle infused controls. The majority of the cells were nestin+ after 6 days of infusion. Seven weeks post-infusion, 22 and 30% of the number of BrdU+ cells induced to proliferate after 6 days of EGF+FGF2+H infusions were still detected around the fourth ventricle and central canal of the spinal cord, respectively. Analysis of the fates of the remaining cells showed that a small percentage of BrdU+ cells around the fourth ventricle and in the white matter of the spinal cord differentiated into astrocytes and oligodendrocytes. BrdU+ neurons were not found in the brainstem or in the grey matter of the cervical spinal cord 7 weeks post-infusion. These results show that endogenous stem cells and progenitors around the fourth ventricle and central canal of the spinal cord proliferate in response to exogenously applied growth factors, but unlike in the lateral ventricle where they generate some new neurons, they only produce new astrocytes and oligodendrocytes at 7 weeks post-infusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383233     DOI: 10.1046/j.1460-9568.2002.02181.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  68 in total

1.  Functional and molecular clues reveal precursor-like cells and immature neurones in the turtle spinal cord.

Authors:  Raúl E Russo; Anabel Fernández; Cecilia Reali; Milka Radmilovich; Omar Trujillo-Cenóz
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

2.  Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography.

Authors:  Maria Adele Rueger; Heiko Backes; Maureen Walberer; Bernd Neumaier; Roland Ullrich; Marie-Lune Simard; Beata Emig; Gereon Rudolf Fink; Mathias Hoehn; Rudolf Graf; Michael Schroeter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 3.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

4.  Possible Radiation Sensitisation by Trastuzumab Leading to Radiation-Induced Myelitis.

Authors:  Alastair B Law; Tamasin Evans; Richard L Hayward; Geoffrey S Higgins; Katherine L Murray; David Summers; Ian H Kunkler
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

5.  Revisiting neural stem cell identity.

Authors:  Masato Nakafuku; Motoshi Nagao; Andrew Grande; Alessandro Cancelliere
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-14       Impact factor: 11.205

6.  The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke.

Authors:  Rebecca Klein; Nicolas Mahlberg; Maurice Ohren; Anne Ladwig; Bernd Neumaier; Rudolf Graf; Mathias Hoehn; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Maria Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

7.  Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis.

Authors:  Johan Holmberg; Annika Armulik; Kirsten-André Senti; Karin Edoff; Kirsty Spalding; Stefan Momma; Rob Cassidy; John G Flanagan; Jonas Frisén
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

8.  Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS.

Authors:  Regina C Armstrong
Journal:  Future Neurol       Date:  2007-11

9.  The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.

Authors:  Rebecca Klein; Stefan Blaschke; Bernd Neumaier; Heike Endepols; Rudolf Graf; Meike Keuters; Joerg Hucklenbroich; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Michael Schroeter; Maria Adele Rueger
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

10.  Co-evolution of breast-to-brain metastasis and neural progenitor cells.

Authors:  Josh Neman; Cecilia Choy; Claudia M Kowolik; Athena Anderson; Vincent J Duenas; Sarah Waliany; Bihong T Chen; Mike Y Chen; Rahul Jandial
Journal:  Clin Exp Metastasis       Date:  2013-02-28       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.